Fifth Third Bancorp’s Standard BioTools LAB Stock Holding History

Fifth Third Bancorp’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.07K	Buy	6,156 +3,902	+173%	+$3.69K	﹤0.01%	3923
2026 Q1	$2.07K	Buy	+2,254	New	+$2.73K	﹤0.01%	4029
2018 Q3	–	Sell	-516	Closed	-$3K	–	2255
2018 Q2	$3K	Hold	516	–	–	﹤0.01%	2133
2018 Q1	$3K	Hold	516	–	–	﹤0.01%	2130
2017 Q4	$3K	Hold	516	–	–	﹤0.01%	2087
2017 Q3	$3K	Hold	516	–	–	﹤0.01%	2001
2017 Q2	$2K	Hold	516	–	–	﹤0.01%	2050
2017 Q1	$3K	Hold	516	–	–	﹤0.01%	1932
2016 Q4	$4K	Hold	516	–	–	﹤0.01%	1962
2016 Q3	$4K	Buy	+516	New	+$4.74K	﹤0.01%	2012

Other funds holding LAB

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Fifth Third Bancorp's LAB Position: Q2 2026 in Review

Fifth Third Bancorp increased its Standard BioTools (LAB) stake by 173% in Q2 2026, buying an estimated $3.69K and bringing the position to 6,156 shares worth $5.07K. The position accounts for ﹤0.01% of the portfolio, ranked #3923.

Fifth Third Bancorp first reported a position in LAB in Q3 2016 and has held it in 10 quarters since. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

Fifth Third Bancorp held 6,156 shares of Standard BioTools worth $5.07K as of Q2 2026.
Fifth Third Bancorp bought 3,902 Standard BioTools shares in Q2 2026, an estimated $3.69K.
Standard BioTools made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3923 holding.
Fifth Third Bancorp first reported a position in Standard BioTools in Q3 2016 and has held it in 10 quarters since.
144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.